# Effect of Magnesium and Levocarnitine on Metabolic and Clinical Outcomes in Women With Polycystic Ovarian Syndrome (PCOS)

> **NCT07298564** · NA · RECRUITING · sponsor: **Behnood Abbasi** · enrollment: 84 (estimated)

## Conditions studied

- Polycystic Ovary Syndrome (PCOS)

## Interventions

- **DIETARY_SUPPLEMENT:** Magnesium 500 mg
- **DIETARY_SUPPLEMENT:** Levocarnitine 1000 mg
- **DIETARY_SUPPLEMENT:** Placebo
- **DIETARY_SUPPLEMENT:** Magnesium 500 mg
- **DIETARY_SUPPLEMENT:** Placebo Levocarnitine

## Key facts

- **NCT ID:** NCT07298564
- **Lead sponsor:** Behnood Abbasi
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-30
- **Primary completion:** 2026-10-30
- **Final completion:** 2026-11-30
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2025-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07298564

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07298564, "Effect of Magnesium and Levocarnitine on Metabolic and Clinical Outcomes in Women With Polycystic Ovarian Syndrome (PCOS)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07298564. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*